Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients
Top Cited Papers
- 31 August 2011
- journal article
- review article
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 41 (1), 61-70
- https://doi.org/10.1016/j.semarthrit.2010.09.002
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- The First Decade of Biologic TNF Antagonists in Clinical Practice: Lessons Learned, Unresolved Issues and Future DirectionsCurrent directions in autoimmunity, 2010
- Infliximab Treatment for Ocular and Extraocular Manifestations of Behçet's DiseaseJapanese Journal of Ophthalmology, 2007
- Behcet's disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatmentAnnals Of The Rheumatic Diseases, 2006
- Successful treatment of life-threatening intestinal ulcer in Behçet’s disease with infliximab: rapid healing of Behçet’s ulcer with infliximabClinical Rheumatology, 2006
- Pulmonary aneurysms and intracardiac thrombi due to Behçet’s disease in an African-American adolescent with oculocutaneous albinismClinical Rheumatology, 2006
- Adalimumab: a new modality for Behcet's disease?Annals Of The Rheumatic Diseases, 2006
- Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profileAnnals Of The Rheumatic Diseases, 2006
- Adalimumab for sight-threatening uveitis in Behçet's diseaseEye, 2006
- Tumour necrosis factor α inhibitors in the treatment of childhood uveitisRheumatology, 2006
- Behçet's DiseaseThe New England Journal of Medicine, 1999